- 专利标题: Novel compounds and compositions as cathepsin inhibitors
-
申请号: US11296782申请日: 2005-12-07
-
公开(公告)号: US20060089357A1公开(公告)日: 2006-04-27
- 发明人: Michael Graupe , James Palmer , John Patterson , Stephen Pickett , David Aldous , Sukanthini Thurairatnam , Andreas Timm , Frank Halley , Justine Lai , John Link , Jiayao Li
- 申请人: Michael Graupe , James Palmer , John Patterson , Stephen Pickett , David Aldous , Sukanthini Thurairatnam , Andreas Timm , Frank Halley , Justine Lai , John Link , Jiayao Li
- 申请人地址: US NJ Bridgewater US CA South San Francisco
- 专利权人: Aventis Pharmaceuticals Inc.,Axys Pharmaceuticals, Inc.
- 当前专利权人: Aventis Pharmaceuticals Inc.,Axys Pharmaceuticals, Inc.
- 当前专利权人地址: US NJ Bridgewater US CA South San Francisco
- 主分类号: A61K31/537
- IPC分类号: A61K31/537 ; C07D265/30
摘要:
The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
信息查询